By Jaime Llinares Taboada
The U.K. Competition and Markets Authority said Friday that it has decided it won't refer Thermo Fisher Scientific Inc.'s planned $17.4 billion acquisition of pharmaceutical-testing company PPD Inc. to a phase 2 investigation.
The regulator had announced a probe into the deal in October, to see if it would lead to a lessening of competition.
Write to Jaime Llinares Taboada at firstname.lastname@example.org; @JaimeLlinaresT
(END) Dow Jones Newswires